Hepatitis C virus and systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 3, Issue 3, 1997, Pages 153-157

  Bronson, Wendell ^b   McMurray, Robert W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Glomerulonephritis; Hepatitis C virus; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CORTICOSTEROID THERAPY; FEMALE; GLOMERULONEPHRITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS DIAGNOSIS;

EID: 0030926019     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199706000-00009     Document Type: Article

References (35)

1. Alter HJ. To C or not to C: these are the questions. Blood 1995;85:1681-95.
2. Sorrell MF. Clinical Crossroads: A 47 year old man with asymptomatic Hepatitis C infection. JAMA 1996;275:1023-8.
3. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, et al. Extrahepatic immunologie manifestations in chronic hepatitis C virus serotypes. Ann Intern Med 1995;122:169-73.
4. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-19.
5. Kawamoto H, Sakaguchi K, Takaki A, Ogawa S, Tsuji T. Autoimmune responses as assessed by hypergammaglobulinemia and the presence of autoantibodies in patients with chronic hepatitis C. Acta Medica Okayama 1993;47: 305-10.
6. Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus- infected patients with mixed cryoglobulinemia. Hepatology 1995;21:305-12.
7. Szymanski IO, Pullman JM, Underwood JM. Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II. Am J Clin Pathol 1994;102:278-83.
8. Bon E, Cantarel A, Moulinier L, Laroche M, Duffaut M, Arlet P, et al. Rheumatic manifestations chronic hepatitis C and response to treatment with interferon alpha. Revue du Rhumatisme [Edition Française] 1994;61:497- 504.
9. Siegel LB, Cohn L, Nashel D. Rheumatic manifestations of hepatitis C infection. Semin Arthritis Rheum 1993;23:149-54.
10. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117: 573-7.
11. Daud MS, Gibson LE, Dauod S, el-Azhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clinic Proceedings 1995;70:559- 64.
12. Sawada T, Hirohata S, Inoue T. Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 1991;34:1620-1.
13. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialoadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
14. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995; 38:437-9.
15. Johnson RJ, Wilson R, Yamabe H, Couser W, Alpers CE, Wener MH, et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994;46:1255-63.
16. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G. Hepatitis C virus and membranous glomerulonephritis [letter]. Nephron 1991;59: 319-20.
17. Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995;6:220-3.
18. Johnson RJ, Gretch DR, Couser WG, Alpers CE, Wilson J, Chung M, et al. Hepatitis-C virus-associated glomerulonephritis. Effect of alpha interferon. Kidney Int 1994;46:1700-4.
19. Borisova VV, Krel' PE. Systemic lupus erythematosus etiologically due to the hepatitis B and C viruses. [Russian] Terapevticheskii Arkhiv 1992;64:92-3.
20. Kimura Y, Kajiyama K, Nomura H. Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus. Fukuoka Igaku Zasshi-Fukuoka Acta Medica [Japanese] 1994;85:329-33.
21. Parke AL, Parke DV. Hepatic disease, the gastrointestinal tract, and rheumatic disease. Curr Opin Rheumatol 1994; 6:85-94.
22. MacKay IR. Hepatic disease and systemic lupus erythematosus. In: Lahita RG, editor. Systemic lupus erythematosus. New York: Churchill Livingstone, 1992:761-5.
23. Dhar JP, Dhar R, Mutchnick MG. Hepatitis c and autoimmunity [abstract]. Arthritis Rheum 1994;37:S233.
24. Sikander F. Cryoglobulin studies in systemic lupus erythematosus. J Post Grad Med 1989; 35:139-45.
25. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long term follow-up of 40 patients. Am J Med 1980;69:287-97.
26. Marchesoni A, Battafarano N, Podico M, Tosi S. Hepatitis C virus antibodies and systemic lupus erythematosus (letter). Clin Exp Rheumatol 1995;13:267-8.
27. Bellary S, Schiano T, Hartman G, Black M. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine. Ann Intern Med 1995;123: 32-4.
28. Savage K, Dhillon AP, Schmilovitz-Weiss H, el-Batanony M, Brown D, Dusheiko G, et al. Detection of HCV-RNA in paraffin embedded liver biopsies from patients with autoimmune hepatitis. J Hepatology 1995; 22:27-34.
29. Levey JM, Bjornsson B, Banner B, Kuhns M, Malhotra R, Whitman N, et al. Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature. Medicine 1994;73: 53-67.
30. Quigg RJ, Brathwaite M., Gardner DF. Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Am J Kidney Dis 1995;25:798-800.
31. Ronnblom LE, Ahn GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115:178-83.
32. Fried MW, Hoofnagle JH. Therapy of Hepatitis C. Semin Liv Dis 1995;15:82-91.
33. Wright T, Terrault N. Interferon and hepatitis C. N Eng J Med 1995;332:1509-11.
34. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa 2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.
35. Arend SM, Hagen EC, Kroes AC, Bruijn JA, van der Woude FJ. Activation of chronic hepatitis C virus infection by cyclophosphamide in a patient with cANCA-positive vasculitis. Nephrol Dial Transplant 1995;10:884-7.